A series of isostructural hybrid bimetallic metal-organic frameworks (MOFs), Ni(x)M(1-x)-ITHDs [M = Zn(II), Co(II)], have been prepared via a conventional solvothermal reaction in the presence of varying mole ratios of Ni(II)/Zn(II) or Ni(II)/Co(II) mixed metal ions. While a critical amount of the doped Ni(II) ion (more than ≈0.2 mol fraction) is needed to have any enhancement of the framework stability of the hybrid bimetallic NixZn1-x-ITHDs, even a very small amount of the doped Ni(II) ion (≈0.1 mol fraction) produced a full enhancement of the framework stability of the hybrid bimetallic Ni(x)Co(1-x)-ITHDs. The highly porous and rigid Ni(x)Co(1-x)-ITHDs activated via a conventional vacuum drying process shows a Brunauer-Emmett-Teller specific surface area of 5370 m(2) g(-1), which is comparable to that of pure Ni-ITHD. The CO2 uptake capacities of Ni-ITHD and Ni(0.11)Co(0.89)-ITHD (2.79 and 2.71 g g(-1), respectively) at 1 bar and 195 K are larger than those of any other reported MOFs under similar conditions and the excess CO2 uptake capacity at 40 bar and 295 K (≈1.50 g g(-1)) is comparable to those of other MOFs, which are activated via the supercritical carbon dioxide drying process, with similar pore volumes.
A general strategy was developed for edge-directed self-assembly of tetragonal metal-organic polyhedra (MOPs) having a C(4) symmetry Cu(II)(2)(COO)(4) paddle-wheel as a secondary building unit, using C(2) symmetric dicarboxylic ligands as pincer-type primary building units.
A twofold interpenetrating polyhedron-based metal-organic framework with high hydrothermal stability was prepared using a rigid and bent C(2)-symmetric ligand containing two 3,5-benzenedicarboxylate units, which have large surface area and high uptake capacities for various gas molecules.
Single crystalline hollow metal-organic frameworks (MOFs) with cavity dimensions on the order of several micrometers and hundreds of micrometers were prepared using a metal-organic polyhedron single crystal as a sacrificial hard template. The hollow nature of the MOF crystal was confirmed by scanning electron microscopy of the crystal sliced using a focused ion beam.
Solvothermal reactions of manganese(II) chloride tetrahydrate with a bis-tetrazole ligand, 2,6-di(1H-tetrazol-5-yl)naphthalene (H(2)NDT), in N,N'-dimethylformamide (DMF)/MeOH mixed solvent at two slightly different temperatures, 75 and 100 °C, led to two different metal-organic frameworks (MOFs), [Mn(II)(3)O(HNDT)(2)(NDT)(DMF)(3)] (1) and [Mn(II)(5)O(2)(HNDT)(2)(NDT)(2)(DMF)(8)] (2), with different net topologies. Single-crystal X-ray diffraction studies reveal that 1 is constructed from an unprecedented trinuclear building block, [Mn(II)(3)O(CN(4))(6)], as a 6-connected trigonal prismatic secondary building unit (SBU) of topological D(3h) site symmetry, and that the ligand in the HNDT(-1)/NDT(2-) deprotonation states is a linker, where two tetrazole (CN(4)) groups of the ligand are connected via a rigid naphthyl group. The tetrazole groups in 1 adopt a 1,2-μ-bridging mode with the manganese(II) ions to form a μ(3)-oxo trinuclear SBU. The trigonalprismatic SBU in 1 is connected to six neighboring SBUs to form a three-dimensional MOF of acs net topology. 2 is constructed from an unprecedented pentanuclear building block, [Mn(II)(5)O(2)(CN(4))(8)], as an 8-connected tetragonal prismatic SBU of topological D(4h) site symmetry. The tetrazole groups in 2 adopt monodentate, 1,2-μ- and 2,3-μ-bridging bidentate and 1,2,3-μ-bridging tridentate binding modes with the manganese(II) centers to form a bis-μ(3)-oxo pentanuclear SBU of local C(2) site symmetry. The tetragonal prismatic SBU in 2 is connected to eight neighboring SBUs to form a 3-D MOF of bcu net topology.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.